Amicogen, Inc. (KOSDAQ:092040)
South Korea
· Delayed Price · Currency is KRW 3,170.00
-15.00 (-0.47%)
May 14, 2025, 11:39 AM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Raw Drug Substance | 120.22B |
Log In |
Log In |
Log In |
Log In |
| Raw Drug Substance Growth | 12.08% |
Log In |
Log In |
Log In |
Log In |
| Biopharmaceutical | 55.18B |
Log In |
Log In |
Log In |
Log In |
| Biopharmaceutical Growth | 13.37% |
Log In |
Log In |
Log In |
Log In |
| Consolidated Adjustment | -15.50B |
Log In |
Log In |
Log In |
Log In |
| Consolidated Adjustment Growth | 33.09% |
Log In |
Log In |
Log In |
Log In |
| Rare Disease Drugs | - |
Log In |
Log In |
Log In |
Log In |
| Rare Disease Drugs Growth | - |
Log In |
Log In |
Log In |
Log In |
| Product | - |
Log In |
Log In |
Log In |
Log In |
| Product Growth | - |
Log In |
Log In |
Log In |
Log In |
| Merchandise | - |
Log In |
Log In |
Log In |
Log In |
| Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In |
| Service | - |
Log In |
Log In |
Log In |
Log In |
| Service Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Overseas | 132.87B |
Log In |
Log In |
Log In |
Log In |
| Overseas Growth | 470.63% |
Log In |
Log In |
Log In |
Log In |
| South Korea | 27.04B |
Log In |
Log In |
Log In |
Log In |
| South Korea Growth | -77.66% |
Log In |
Log In |
Log In |
Log In |